#TransMedics
ALERT 🚨: TMDX performance check moved +32.56% since 2026-05-25. We chose this because TransMedics has a differentiated organ-preservation platform, integrated logistics and a...

https://www.narrowit.com/investment-analysis/stock/tmdx-2026-05-25
#InvestmentPerformance #TMDX #Stock #MarketUpdate
TMDX Stock Analysis 2026-05-25 | Narrowit.com
Open the Narrowit.com stock research report for TMDX dated 2026-05-25, including valuation, performance, risk factors, entry strategy, and scorecard analysis.
www.narrowit.com
November 14, 2026 at 1:18 AM
TransMedics' Third Quarter 2026 Financial Achievements and Future Catalysts#USA#TransMedics#Andover#OCS#ENHANCE
TransMedics' Third Quarter 2026 Financial Achievements and Future Catalysts
TransMedics Group announces a significant financial performance in Q3 2026, leading to increased revenue forecasts and expansion plans. Explore their innovative technologies.
third-news.com
November 5, 2026 at 9:15 PM
🫀 #$TMDX +13.9% after-hours! TransMedics smashed Q3: EPS $0.46 vs $0.29, revenue $203M (+41% YoY), service revenue +60%. Full-year guide raised to $764–774M. 🚀 @TransMedics @Nasdaq Stock closed -5.2% first, and EPS is still down 30% YoY. Thin after-hours liquidity can reverse, 💰 #TMDX #Earnings
November 5, 2026 at 10:53 PM
ALERT 🚨: TMDX performance check moved +28.01% since 2026-05-25. We chose this because TransMedics has a differentiated organ-preservation platform, integrated logistics and a...

https://www.narrowit.com/investment-analysis/stock/tmdx-2026-05-25
#InvestmentPerformance #TMDX #Stock #MarketUpdate
TMDX Stock Analysis 2026-05-25 | Narrowit.com
Open the Narrowit.com stock research report for TMDX dated 2026-05-25, including valuation, performance, risk factors, entry strategy, and scorecard analysis.
www.narrowit.com
November 7, 2026 at 1:28 AM
TransMedics (TMDX) reportó ingresos de US$203 millones en el Q3'26 (+41% interanual), por encima de lo esperado. EPS de US$0,46. Subió su guidance de ingresos para el año a US$764-774 millones. El protocolo de la FDA habilita 90 pacientes más para ENHANCE Heart.
November 6, 2026 at 12:20 AM
🚨 $TMDX
On November 5, 2026, TransMedics Group, Inc. issued a press release announcing the Company’s financial results for the quarter ended September 30, 2026. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.
SEC Filing: TMDX
Click to view the official SEC document.
www.sec.gov
November 5, 2026 at 9:03 PM
TransMedics is equipping its 22 Embraer Phenom 300E organ transport aircraft with Gogo Galileo HDX LEO satellite connectivity for real-time clinical monitoring in flight. Full US fleet expected…
https://airpronews.com/2026/11/01/transmedics-selects-gogo-galileo-hdx-for-organ-transport-fleet/
November 1, 2026 at 10:46 PM
TransMedics Expands Talent Pool with New Stock Option Grants for Employees#USA#stock_options#TransMedics#Andover#organ_transplant
TransMedics Expands Talent Pool with New Stock Option Grants for Employees
TransMedics Group, Inc. announces significant stock option grants and RSUs awarded to employees as part of their hiring strategy under NASDAQ rules.
third-news.com
October 30, 2026 at 8:28 PM
Another example of growing adoption of Eutelsat's LEO services across the aviation sector ✈️

TransMedics has selected Gogo Galileo HDX - connected by OneWeb - to support organ transport missions across the United States, helping keep critical operations connected when every second counts.
October 27, 2026 at 1:47 PM
$GOGO · $TMDX 📝

TransMedics Group, Inc. selected Gogo Inc.'s Gogo Galileo HDX to equip 22 Embraer Phenom 300E organ-transport aircraft with inflight connectivity.

Timely market event

More market highlights:
https://rayvio.app/dashboard/?utm_source=lifatpt
October 27, 2026 at 11:03 AM
Random Stock
Ticker: $TMDX
Company: TransMedics Group, Inc.
Sector: Healthcare
Industry: Medical Devices
# Employees: 898
Recent Close: $76.52
52-Week High: $156.00
52-Week High Date: 12-02-2025
% Off 52-Week High: -50.95%
52-Week Low: $60.10
October 16, 2026 at 8:00 AM
ALERT 🚨: TMDX performance check moved +13.40% since 2026-05-25. We chose this because TransMedics has a differentiated organ-preservation platform, integrated logistics and a...

https://www.narrowit.com/investment-analysis/stock/tmdx-2026-05-25
#InvestmentPerformance #TMDX #Stock #MarketUpdate
TMDX Stock Analysis 2026-05-25 | Narrowit.com
Open the Narrowit.com stock research report for TMDX dated 2026-05-25, including valuation, performance, risk factors, entry strategy, and scorecard analysis.
www.narrowit.com
October 13, 2026 at 12:19 AM